...
search icon
  • Apple, Inc AAPL
  • S&P 500 ETF Trust SPDR SPY
  • Alphabet Inc. - Class A Shares GOOGL
  • Microsoft Corporation MSFT
  • Meta Platforms Inc META
  • Netflix, Inc. NFLX
  • Amazon.com Inc. AMZN
  • Spotify Technology SA SPOT
    klto-img

    Klotho Neurosciences, Inc., Common Stock

    KLTO

    NMQ

    $0.2246

    +$0.03

    (15.23%)

    1D
    Industry: Biotechnology Sector: Health Care

    Analyst Forecast

    Overview Returns Financials Ratios News FAQs

    Price Chart

    Key Metrics

    Market Cap info-icon
    This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
     $4.74M
    P/E Ratio info-icon
    This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
     0
    Volume info-icon
    This is the total number of shares traded during the most recent trading day.
     73.82M
    Avg Volume info-icon
    This is the average number of shares traded during the most recent 30 days.
     0
    Dividend Yield info-icon
    This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
     0.00%
    Beta info-icon
    This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
     0.02
    52-week Range info-icon
    This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
    $0.11 L
    $8.11 H
    $0.2246

    About Klotho Neurosciences, Inc., Common Stock

    Klotho Neurosciences, Inc. develops medicines for the treatment of cancer, cardiovascular, and neurodegenerative disorders. Its lead gene therapy product candidates comprise KLTO-101 for the treatment or prevention of Alzheimer's disease; and KLTO-202, a gene therapy product for treatment and prevention of Lou Gehrig's disease. The company was formerly known as Anew Medical, Inc. and changed its name to Klotho Neurosciences, Inc. in September 2024. Klotho Neurosciences, Inc. is based in Omaha, Nebraska. more

    Industry: BiotechnologySector: Health Care

    Returns

    Time FrameKLTOSectorS&P500
    1-Week Return35.3%0.31%4.65%
    1-Month Return34.49%-2.35%12.32%
    3-Month Return-43.85%-7.91%-3.48%
    6-Month Return-35.64%-6.24%0.38%
    1-Year Return-96.26%-8.86%11.69%
    3-Year Return-97.71%2.73%47.55%
    5-Year Return-97.73%31.45%100.22%

    Financials

    Dec '21Dec '22Dec '23Dec '24
    Total Revenue----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Cost of Revenue----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Gross Profit----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Gross Margin----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Operating Expenses1.11M574.37K631.32K5.54M[{"date":"2021-12-31","value":20.02,"profit":true},{"date":"2022-12-31","value":10.37,"profit":true},{"date":"2023-12-31","value":11.4,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
    Operating Income(1.11M)(574.37K)(631.32K)(5.54M)[{"date":"2021-12-31","value":-110906900,"profit":false},{"date":"2022-12-31","value":-57437400,"profit":false},{"date":"2023-12-31","value":-63132200,"profit":false},{"date":"2024-12-31","value":-554023600,"profit":false}]
    Total Non-Operating Income/Expense44.00(48.59K)(152.35K)(966.74K)[{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-110420.45,"profit":false},{"date":"2023-12-31","value":-346250,"profit":false},{"date":"2024-12-31","value":-2197134.09,"profit":false}]
    Pre-Tax Income(1.11M)(598.59K)(707.46K)(6.15M)[{"date":"2021-12-31","value":-110902500,"profit":false},{"date":"2022-12-31","value":-59859300,"profit":false},{"date":"2023-12-31","value":-70745800,"profit":false},{"date":"2024-12-31","value":-615037200,"profit":false}]
    Income Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Income After Taxes----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Income From Continuous Operations(1.11M)(598.59K)(707.46K)(6.15M)[{"date":"2021-12-31","value":-110902500,"profit":false},{"date":"2022-12-31","value":-59859300,"profit":false},{"date":"2023-12-31","value":-70745800,"profit":false},{"date":"2024-12-31","value":-615037200,"profit":false}]
    Income From Discontinued Operations----[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
    Net Income(1.11M)(598.59K)(707.46K)(6.15M)[{"date":"2021-12-31","value":-110902500,"profit":false},{"date":"2022-12-31","value":-59859300,"profit":false},{"date":"2023-12-31","value":-70745800,"profit":false},{"date":"2024-12-31","value":-615037200,"profit":false}]
    EPS (Diluted)-0.080.11(0.31)[{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":76.45,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":-281.78,"profit":false}]

    Ratios

    Liquidity

    These ratios help you determine the liquidity of the company. Higher is better.

    KLTO
    Cash Ratio 0.05
    Current Ratio 0.13

    Asset Efficiency

    These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

    KLTO
    ROA (LTM) -23.57%
    ROE (LTM) 0.00%

    Liabilities

    These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

    KLTO
    Debt Ratio Lower is generally better. Negative is bad. 0.52
    Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.48

    Valuation

    These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

    KLTO
    Trailing PE NM
    Forward PE NM
    P/S (TTM) 0.00
    P/B 43.36
    Price/FCF NM
    EV/R 0.00
    EV/Ebitda NM

    Discover more

    Tsla

    Tesla, Inc.
    aaple

    Apple, Inc.
    GOOGL

    Alphabet Inc. - Class A Shares
    META

    Meta Platforms Inc
    AMZN

    Amazon.com Inc.
    Microsoft

    Microsoft Corporation
    NVDA

    NVIDIA Corporation
    BRK

    Berkshire Hathaway Inc. Hld B
    LLY

    Eli Lilly and Company

    FAQs

    What is Klotho Neurosciences, Inc. share price today?

    Klotho Neurosciences, Inc. (KLTO) share price today is $0.2246

    Can Indians buy Klotho Neurosciences, Inc. shares?

    Yes, Indians can buy shares of Klotho Neurosciences, Inc. (KLTO) on Vested. To buy Klotho Neurosciences, Inc. from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in KLTO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

    Can Fractional shares of Klotho Neurosciences, Inc. be purchased?

    Yes, you can purchase fractional shares of Klotho Neurosciences, Inc. (KLTO) via the Vested app. You can start investing in Klotho Neurosciences, Inc. (KLTO) with a minimum investment of $1.

    How to invest in Klotho Neurosciences, Inc. shares from India?

    You can invest in shares of Klotho Neurosciences, Inc. (KLTO) via Vested in three simple steps:

    • Click on Sign Up or Invest in KLTO stock at the top of this page
    • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
    • Transfer USD funds to your US Brokerage account and start investing in Klotho Neurosciences, Inc. shares
    What is Klotho Neurosciences, Inc. 52-week high and low stock price?

    The 52-week high price of Klotho Neurosciences, Inc. (KLTO) is $8.11. The 52-week low price of Klotho Neurosciences, Inc. (KLTO) is $0.11.

    What is Klotho Neurosciences, Inc. price-to-book (P/B) ratio?

    The price-to-book (P/B) ratio of Klotho Neurosciences, Inc. (KLTO) is 43.36

    What is the Market Cap of Klotho Neurosciences, Inc.?

    The market capitalization of Klotho Neurosciences, Inc. (KLTO) is $4.74M

    What is Klotho Neurosciences, Inc.’s stock symbol?

    The stock symbol (or ticker) of Klotho Neurosciences, Inc. is KLTO

    Feedback

    Signup to access all features and start your US investing journey!

    • Open your account in minutes
    • Take your portfolio global, starting at just $1
    Get started

    Add ticker to compare

    Scroll to Top